Peter B Forgacs1,2,3, Orrin Devinsky4, Nicholas D Schiff1,2,3. 1. Feil Family Brain and Mind Research Institute, Weill Cornell Medical College, New York, NY. 2. Department of Neurology, Weill Cornell Medical College, New York, NY. 3. Rockefeller University, New York, NY. 4. Department of Neurology, New York University, New York, NY.
Abstract
OBJECTIVE: Survivors of prolonged (>2 weeks) post-cardiac arrest (CA) coma are expected to remain permanently disabled. We aimed to investigate 3 outlier patients who ultimately achieved independent functional outcomes after prolonged post-CA coma to identify electroencephalographic (EEG) markers of their recovery potential. For validation purposes, we also aimed to evaluate these markers in an independent cohort of post-CA patients. METHODS: We identified 3 patients with late recovery from coma (17-37 days) following CA who recovered to functionally independent behavioral levels. We performed spectral power analyses of available EEGs during prominent burst suppression patterns (BSP) present in all 3 patients. Using identical methods, we also assessed the relationship of intraburst spectral power and outcomes in a prospectively enrolled cohort of post-CA patients. We performed chart reviews of common clinical, imaging, and EEG prognostic variables and clinical outcomes for all patients. RESULTS: All 3 patients with late recovery from coma lacked evidence of overwhelming cortical injury but demonstrated prominent BSP on EEG. Spectral analyses revealed a prominent theta (~4-7Hz) feature dominating the bursts during BSP in these patients. In the prospective cohort, similar intraburst theta spectral features were evident in patients with favorable outcomes; patients with BSP and unfavorable outcomes showed either no features, transient burst features, or decreasing intraburst frequencies with time. INTERPRETATION: BSP with theta (~4-7Hz) peak intraburst spectral power after CA may index a recovery potential. We discuss our results in the context of optimizing metabolic substrate availability and stimulating the corticothalamic system during recovery from prolonged post-CA coma. ANN NEUROL 2020;87:618-632.
OBJECTIVE: Survivors of prolonged (>2 weeks) post-cardiac arrest (CA) coma are expected to remain permanently disabled. We aimed to investigate 3 outlier patients who ultimately achieved independent functional outcomes after prolonged post-CA coma to identify electroencephalographic (EEG) markers of their recovery potential. For validation purposes, we also aimed to evaluate these markers in an independent cohort of post-CA patients. METHODS: We identified 3 patients with late recovery from coma (17-37 days) following CA who recovered to functionally independent behavioral levels. We performed spectral power analyses of available EEGs during prominent burst suppression patterns (BSP) present in all 3 patients. Using identical methods, we also assessed the relationship of intraburst spectral power and outcomes in a prospectively enrolled cohort of post-CA patients. We performed chart reviews of common clinical, imaging, and EEG prognostic variables and clinical outcomes for all patients. RESULTS: All 3 patients with late recovery from coma lacked evidence of overwhelming cortical injury but demonstrated prominent BSP on EEG. Spectral analyses revealed a prominent theta (~4-7Hz) feature dominating the bursts during BSP in these patients. In the prospective cohort, similar intraburst theta spectral features were evident in patients with favorable outcomes; patients with BSP and unfavorable outcomes showed either no features, transient burst features, or decreasing intraburst frequencies with time. INTERPRETATION:BSP with theta (~4-7Hz) peak intraburst spectral power after CA may index a recovery potential. We discuss our results in the context of optimizing metabolic substrate availability and stimulating the corticothalamic system during recovery from prolonged post-CA coma. ANN NEUROL 2020;87:618-632.
Authors: Clifton W Callaway; Michael W Donnino; Ericka L Fink; Romergryko G Geocadin; Eyal Golan; Karl B Kern; Marion Leary; William J Meurer; Mary Ann Peberdy; Trevonne M Thompson; Janice L Zimmerman Journal: Circulation Date: 2015-11-03 Impact factor: 29.690
Authors: E A Matthews; J Magid-Bernstein; A Presciutti; A Rodriguez; D Roh; S Park; J Claassen; S Agarwal Journal: Resuscitation Date: 2017-03-06 Impact factor: 5.262
Authors: Lionel Velly; Vincent Perlbarg; Thomas Boulier; Nicolas Adam; Sebastien Delphine; Charles-Edouard Luyt; Valentine Battisti; Gregory Torkomian; Charlotte Arbelot; Russell Chabanne; Betty Jean; Carol Di Perri; Steven Laureys; Giuseppe Citerio; Alessia Vargiolu; Benjamin Rohaut; Nicolas Bruder; Nadine Girard; Stein Silva; Vincent Cottenceau; Thomas Tourdias; Olivier Coulon; Bruno Riou; Lionel Naccache; Rajiv Gupta; Habib Benali; Damien Galanaud; Louis Puybasset Journal: Lancet Neurol Date: 2018-02-27 Impact factor: 44.182
Authors: Victor N Petzinka; Christian Endisch; Kaspar J Streitberger; Farid Salih; Christoph J Ploner; Christian Storm; Jens Nee; Christoph Leithner Journal: Resuscitation Date: 2018-07-07 Impact factor: 5.262
Authors: Samuel B Snider; David Fischer; Morgan E McKeown; Alexander Li Cohen; Frederic L W V J Schaper; Edilberto Amorim; Michael D Fox; Benjamin Scirica; Matthew B Bevers; Jong Woo Lee Journal: Neurology Date: 2022-01-11 Impact factor: 9.910
Authors: J Javier Provencio; J Claude Hemphill; Jan Claassen; Brian L Edlow; Raimund Helbok; Paul M Vespa; Michael N Diringer; Len Polizzotto; Lori Shutter; Jose I Suarez; Robert D Stevens; Daniel F Hanley; Yama Akbari; Thomas P Bleck; Melanie Boly; Brandon Foreman; Joseph T Giacino; Jed A Hartings; Theresa Human; Daniel Kondziella; Geoffrey S F Ling; Stephan A Mayer; Molly McNett; David K Menon; Geert Meyfroidt; Martin M Monti; Soojin Park; Nader Pouratian; Louis Puybasset; Benjamin Rohaut; Eric S Rosenthal; Nicholas D Schiff; Tarek Sharshar; Amy Wagner; John Whyte; DaiWai M Olson Journal: Neurocrit Care Date: 2020-08 Impact factor: 3.210
Authors: Jan Claassen; Yama Akbari; Sheila Alexander; Mary Kay Bader; Kathleen Bell; Thomas P Bleck; Melanie Boly; Jeremy Brown; Sherry H-Y Chou; Michael N Diringer; Brian L Edlow; Brandon Foreman; Joseph T Giacino; Olivia Gosseries; Theresa Green; David M Greer; Daniel F Hanley; Jed A Hartings; Raimund Helbok; J Claude Hemphill; H E Hinson; Karen Hirsch; Theresa Human; Michael L James; Nerissa Ko; Daniel Kondziella; Sarah Livesay; Lori K Madden; Shraddha Mainali; Stephan A Mayer; Victoria McCredie; Molly M McNett; Geert Meyfroidt; Martin M Monti; Susanne Muehlschlegel; Santosh Murthy; Paul Nyquist; DaiWai M Olson; J Javier Provencio; Eric Rosenthal; Gisele Sampaio Silva; Simone Sarasso; Nicholas D Schiff; Tarek Sharshar; Lori Shutter; Robert D Stevens; Paul Vespa; Walter Videtta; Amy Wagner; Wendy Ziai; John Whyte; Elizabeth Zink; Jose I Suarez Journal: Neurocrit Care Date: 2021-07-08 Impact factor: 3.210
Authors: Brian L Edlow; Jan Claassen; Jonathan D Victor; Emery N Brown; Nicholas D Schiff Journal: Neurocrit Care Date: 2020-11-10 Impact factor: 3.210